StonvexLoading…
StonvexStonvexStonvexCore line items from LGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $2.55B | $2.10B | $1.62B |
Operating Income | $61.58M | $70.35M | $10.26M |
Net Income | $-59.78M | $-28.55M | $-46.03M |
EPS (Diluted) | $-0.57 | Not available | Not available |
Total Assets | $2.68B | $2.35B | Not available |
Total Liabilities | $1.89B | $2.15B | Not available |
Cash & Equivalents | $230.17M | $81.17M | Not available |
Free Cash Flow OCF − CapEx | $218.93M | $10.26M | $16.84M |
Shares Outstanding | 59.38M | Not available | Not available |